心房颤动遗传风险与缺血性卒中机制
研究纳入2374例缺血性卒中和5175例对照,采用房颤遗传风险评分分析其与TOAST卒中亚型的关联。结果显示房颤遗传风险主要与心源性卒中亚型相关,与非心源性卒中亚型无显著关联。
要点
- 房颤遗传风险评分对心源性卒中亚型具有特异性。
- 房颤遗传风险与非心源性卒中亚型无显著关联。
- 不完善的检查和亚型误分类可能限制了对不明原因卒中的关联检测。
核心结论
- 综合房颤遗传风险评分对心源性卒中亚型具有特异性。
研究设计与样本
- 研究纳入2374例门诊缺血性卒中患者和5175例无卒中对照,来自Wellcome Trust病例对照联盟2,采用逻辑回归分析房颤遗传风险与TOAST卒中亚型的关联。
主要发现
- 460例(19.4%)为心源性卒中,498例(21.0%)为大血管性,474例(20.0%)为小血管性,814例(32.3%)为不明原因卒中。
- 多数房颤遗传风险评分与卒中相关,最强关联(P=6×10-4)为944个单核苷酸多态性评分(每个SNP在先前的分析中与房颤关联P<1×10-3)。
- 房颤遗传风险与卒中的关联在心源性卒中亚组中富集(最强P=1.2×10-9,944个SNP评分)。
- 房颤遗传风险与非心源性卒中亚型无显著关联。
临床怎么用
- 房颤遗传风险评分可能有助于临床区分心源性卒中,但尚需未来研究确定其作为生物标志物的实用性。
局限性
- 不完善的检查和亚型误分类可能限制了对不明原因卒中关联的检测能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Atrial fibrillation (AF) is a leading cause of cardioembolic stroke, but the relationship between AF and noncardioembolic stroke subtypes are unclear. Because AF may be unrecognized, and because AF has a substantial genetic basis, we assessed for predisposition to AF across ischemic stroke subtypes. METHODS: We examined associations between AF genetic risk and Trial of Org 10172 in Acute Stroke Treatment stroke subtypes in 2374 ambulatory individuals with ischemic stroke and 5175 without from the Wellcome Trust Case-Control Consortium 2 using logistic regression. We calculated AF genetic risk scores using single-nucleotide polymorphisms associated with AF in a previous independent analysis across a range of preselected significance thresholds. RESULTS: There were 460 (19.4%) individuals with cardioembolic stroke, 498 (21.0%) with large vessel, 474 (20.0%) with small vessel, and 814 (32.3%) individuals with strokes of undetermined cause. Most AF genetic risk scores were associated with stroke, with the strongest association (P=6×10-4) attributed to scores of 944 single-nucleotide polymorphisms (each associated with AF at P<1×10-3 in a previous analysis). Associations between AF genetic risk and stroke were enriched in the cardioembolic stroke subset (strongest P=1.2×10-9, 944 single-nucleotide polymorphism score). In contrast, AF genetic risk was not significantly associated with noncardioembolic stroke subtypes. CONCLUSIONS: Comprehensive AF genetic risk scores were specific for cardioembolic stroke. Incomplete workups and subtype misclassification may have limited the power to detect associations with strokes of undetermined pathogenesis. Future studies are warranted to determine whether AF genetic risk is a useful biomarker to enhance clinical discrimination of stroke pathogeneses.
引用
- Lubitz SA, Parsons OE, Anderson CD, et al. Atrial Fibrillation Genetic Risk and Ischemic Stroke Mechanisms. Stroke. 2017. PMID: 28468926. doi:10.1161/STROKEAHA.116.016198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。